Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations
Publication with shared reference
10.1002/cncr.32572
Home
Publications
Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations
Publication with shared reference
10.1002/cncr.32572
Publications with shared reference:
Clinical utility of hereditary cancer panel testing: Impact of
PALB2
,
ATM
,
CHEK2
,
NBN
,
BRIP1
,
RAD51C
, and
RAD51D
results on patient management and adherence to provider recommendations
0
publications found
Export
Export
Analytics view
Analytics view
Scroll to top